New Deals, Modalities In Sights In Japan After Relatively Quiet 2022

Digital Tools, Cell/Gene Therapies Key Areas?

 
• By Ian Haydock
  
Glasses
A look back and ahead at the Japan pharma commercial landscape in 2022-23 • Source: Shutterstock
In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

SpotifyApple PodcastsWebsite

More from Global Vision

More from In Vivo